Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(20 sites)
Belgium
Universitaire Ziekenhuizen Leuven, Leuven Canada
British Columbia Children's Hospital, Vancouver, British Columbia The University of Western Ontario - Children's Health Research Institute, London, Ontario University of Ottawa - Children's Hospital of Eastern Ontario, Ottawa, Ontario University of Toronto - Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario France
Centre Hospitalier Régional Universitaire de Lille, Lille Centre hospitalier universitaire - Hôpitaux de Marseille, Marseille Hôpital Armand-Trousseau - I-Motion, Paris Germany
Charite-Universitaetsmedizin Berlin, Berlin Universitaetsklinikum Freiburg, Freiburg im Breisgau Italy
Associazione La Nostra Famiglia - IRCCS Eugenio Medea - Bosisio Parini, Lecco Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca' Granda - NeuroMuscular Omnicentre, Milan Università degli Studi di Padova - Azienda Ospedaliera di Padova, Padova Ospedale Pediatrico Bambino Gesù, Roma Policlinico Universitario Agostino Gemelli - Università Cattolica del Sacro Cuore, Roma Netherlands
Leids Universitair Medisch Centrum (LUMC), Leiden Radboud Universitair Medisch Centrum (Radboudumc), Nijmegen United Kingdom
Newcastle upon Tyne Hospitals NHS Foundation Trust - Newcastle University, Newcastle upon Tyne, England Oxford University Hospitals NHS Foundation Trust, Oxford, England NHS Greater Glasgow and Clyde - Royal Hospital for Children, Glasgow, Scotland